Gene polymorphisms in association with self-reported stroke in US adults
Amy Z Fan1, Jing Fang1, Ajay Yesupriya2, Man-huei Chang2, Greta Kilmer1, Meaghan House3, Donald Hayes1, Renée M Ned2, Nicole F Dowling2, Ali H Mokdad1
1National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA; 2Office of Public Health Genomics, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA; 3School of Public Health, Emory University, Atlanta, GA, USA
Purpose: Epidemiologic studies suggest that several gene variants increase the risk of stroke, and population-based studies help provide further evidence. We identified polymorphisms associated with the prevalence of self-reported stroke in US populations using a representative sample.
Methods: Our sample comprised US adults in the Third National Health and Nutrition Examination (NHANES III) DNA bank. We examined nine candidate gene variants within ACE, F2, F5, ITGA2, MTHFR, and NOS3 for associations with self-reported stroke. We used multivariate regression and Cox proportional hazards models to test the association between these variants and history of stroke.
Results: In regression models, the rs4646994 variant of ACE (I/I and I/D genotypes) was associated with higher prevalence adjusted prevalence odds ratio [APOR] = 2.66 [1.28, 5.55] and 2.23 [1.30, 3.85], respectively) compared with the D/D genotype. The heterozygous genotype of MTHFR rs1801131 (A/C) was associated with lower prevalence of stroke (APOR = 0.48 [0.25, 0.92]) compared with A/A and C/C genotypes. For rs2070744 of NOS3, both the C/T genotype (APOR = 1.91 [1.12, 3.27]) and C/C genotype (APOR = 3.31 [1.66, 6.60]) were associated with higher prevalence of stroke compared with the T/T genotype.
Conclusion: Our findings suggest an association between the prevalence of self-reported stroke and polymorphisms in ACE, MTHFR, and NOS3 in a population-based sample.
Keywords: stroke, gene, polymorphisms, NHANES III, gene association analysis
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Readers of this article also read:
Ikuno Y, Fujimoto S, Jo Y, Asai T, Nishida K
Published Date: 15 May 2013
Porter J, Morphet J, Missen K, Raymond A
Published Date: 30 April 2013
Glotzer OS, Fabian T, Chandra A, Bakhos CT
Published Date: 22 April 2013
Niscola P, Palombi M, Trawinska MM, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P
Published Date: 11 April 2013
Hsiao PY, Tien HC, Lo CP, Juang JM, Wang YH, Sung RJ
Published Date: 18 January 2013
Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I
Published Date: 9 February 2012
Chauhan A, Zubair S, Tufail S, Sherwani A, Sajid M, Raman SC, Azam A, Owais M
Published Date: 12 October 2011
Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical
Henry JL, Dableh LJ
Published Date: 5 April 2011
Congenital malformations in Ecuadorian children: urgent need to create a National Registry of Birth Defects
Fabricio González-Andrade, Ramiro López-Pulles
Published Date: 14 April 2010
Eduardo Pimenta, Suzanne Oparil
Published Date: 19 May 2009